ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,505Medicare Part D Prescriptions Filled, Including Refills

Rank: 38 out of 617

$593K Total Retail Price of All Prescriptions

Rank: 54 out of 617

372 Patients Receiving at Least One Drug in Part D
88%Patients 65 Years and Older
45% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Nebraska
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 372 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

23% of this provider’s 372 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

2% of this provider’s 12,138 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$44 was the average price of a prescription from this provider, compared to $49 among peers.

Prescriptions per Patient

36 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Nebraska
LEVOTHYROXINE SODIUM 603 558 1 1
OMEPRAZOLE 529 454 2 3
FUROSEMIDE 519 488 3 4
HYDROCODONE-ACETAMINOPHEN 367 299 S3 4 8
SIMVASTATIN 351 341 5 2
WARFARIN SODIUM 345 342 6 7
POTASSIUM CHLORIDE 321 299 7 10
AMLODIPINE BESYLATE 284 256 8 6
ATENOLOL 222 216 9 17
METFORMIN HCL 205 186 10 9
LANTUS 204 204 11 39
METOPROLOL TARTRATE 193 193 12 11
POLYETHYLENE GLYCOL 3350 187 163 13 32
METOPROLOL SUCCINATE 183 168 14 12
PREDNISONE 183 149 14 31
LISINOPRIL 178 178 16 5
ENALAPRIL MALEATE 177 159 17 34
FLUOXETINE HCL 175 164 18 73
LOVASTATIN 173 171 19 57
GABAPENTIN 167 155 20 16
SERTRALINE HCL 166 162 21 20
ATORVASTATIN CALCIUM 161 134 22 14
HYDROCHLOROTHIAZIDE 152 143 23 13
ZOLPIDEM TARTRATE 151 131 24 23
CITALOPRAM HBR 138 129 25 18
RANITIDINE HCL 124 115 26 40
NAMENDA 122 122 27 35
ISOSORBIDE MONONITRATE ER 122 113 27 52
TAMSULOSIN HCL 113 111 29 26
ALENDRONATE SODIUM 111 111 30 25
DONEPEZIL HCL 105 93 31 30
CARBIDOPA-LEVODOPA 104 97 32 69
AMITRIPTYLINE HCL 95 67 R 33 56
CARVEDILOL 95 95 33 19
AMLODIPINE BESYLATE-BENAZEPRIL 93 93 35 80
TRAMADOL HCL 87 65 36 15
ALLOPURINOL 83 77 37 27
CELEBREX 80 64 38 63
PROPRANOLOL HCL 79 57 39 109
SPIRIVA 78 56 40 61
LEVOFLOXACIN 78 64 40 89
PRAMIPEXOLE DIHYDROCHLORIDE 76 65 42 153
EXELON 75 75 43 156
LYRICA 74 51 44 92
FAMOTIDINE 71 71 45 54
MIRTAZAPINE 69 69 46 50
BISOPROLOL-HYDROCHLOROTHIAZIDE 66 66 47 87
DOXAZOSIN MESYLATE 65 65 48 79
CLOPIDOGREL 64 64 49 53
LOSARTAN-HYDROCHLOROTHIAZIDE 62 62 50 46
ESCITALOPRAM OXALATE 61 52 51 65
OXYBUTYNIN CHLORIDE 61 49 51 88
ENALAPRIL-HYDROCHLOROTHIAZIDE 61 61 51 183
CLONIDINE HCL 60 45 54 55
PRAVASTATIN SODIUM 60 60 54 21
LISINOPRIL-HYDROCHLOROTHIAZIDE 58 51 56 29
FLUTICASONE PROPIONATE 57 44 57 36
TERAZOSIN HCL 57 57 57 96
MELOXICAM 56 48 59 24
DIOVAN 56 56 59 41
ADVAIR DISKUS 56 44 59 38
CYCLOBENZAPRINE HCL 55 33 R 62 74
SYMBICORT 55 41 62 141
DIOVAN HCT 53 47 64 97
NITROFURANTOIN MONO-MACRO 52 40 65 205
DILTIAZEM ER 52 43 65 81
OLANZAPINE 51 51 67 139
NOVOLOG 50 50 68 137
TRIAMTERENE-HCTZ 50 41 68 47
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 18, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.